2026年11月3日星期二
M
Küresel Panorama
Küresel haberler
Working collaboratively to fight scams in Asia Pacific— Google 官方博客Malaysia transport minister still plans to quit, says megaprojects safe— 日经 Nikkei AsiaApple's new CEO delivers first earnings as sales hit record— 日经 Nikkei AsiaJapan's Aisin develops new type of AI chip that cuts energy use 98%— 日经 Nikkei AsiaEthics drive Wardah to pinnacle of Southeast Asia's beauty brands— 日经 Nikkei AsiaCyber insurance inquiries surge at Japan's nonlife insurers— 日经 Nikkei AsiaSingapore's Insignia Ventures backs rural Japan for Davos-inspired academy— 日经 Nikkei AsiaThe great yen rebalancing— 日经 Nikkei AsiaWorking collaboratively to fight scams in Asia Pacific— Google 官方博客Malaysia transport minister still plans to quit, says megaprojects safe— 日经 Nikkei AsiaApple's new CEO delivers first earnings as sales hit record— 日经 Nikkei AsiaJapan's Aisin develops new type of AI chip that cuts energy use 98%— 日经 Nikkei AsiaEthics drive Wardah to pinnacle of Southeast Asia's beauty brands— 日经 Nikkei AsiaCyber insurance inquiries surge at Japan's nonlife insurers— 日经 Nikkei AsiaSingapore's Insignia Ventures backs rural Japan for Davos-inspired academy— 日经 Nikkei AsiaThe great yen rebalancing— 日经 Nikkei Asia

Using artificial intelligence for clinical trial quality assurance in a multi-institutional neurovascular-sparing prostate radiotherapy trial

Kaynak Nature 医学研究6 gün önce
İçerik özeti

Bu site yalnızca başlık ve özet dizini sunar; tam içerik ve telif hakkı asıl yayıncıya aittir, lütfen okumak için orijinal bağlantıya tıklayın.

Orijinal metne git
Ait olduğu kanal
Sağlık
Ait olduğu bölge
Küresel bakış
Orijinal dil
English
Kayıt numarası
health-36317801

Comments 0 comments

No comments yet. Be the first.

Using artificial intelligence for clinical trial quality assurance in a multi-institutional neurovascular-sparing prostate radiotherapy trial · Küresel Panorama